Aramark Ibuprofen
- Manufacturer
- Western First Aid Safety DBA Aramark | Ultra Seal Corporation
- Effective date
- 2021-05-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:40:28
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active Ingredient (in each tablet)
Ibuprofen 200 mg (NSAID)*
OTC - PURPOSE SECTION
Purpose
Ibuprofen 200 mg (NSAID)*.............Pain Reliever Fever Reducer
*nonsteroidal anti-inflammatory drug
INDICATIONS & USAGE SECTION
Uses:
Temporarily Relieves minor aches and pains
due to:
• Headache, toothaches, menstrual cramps,
the common cold,
• muscular aches, minor pain of arthritis
Temporarily reduces fever
WARNINGS SECTION
Warnings:
Allergy Alert: Ibuprofen may cause a severe allergic
reaction, especially in people allergic to aspirin.
Symptoms may include:
• hives, facial swelling, asthma (wheezing), shock,
skin reddening, rash, blisters
Stomach bleeding warning: This product contains an
NSAID, which may cause severe stomach bleeding.
The chance is higher if you:
• are age 60 or older
• have had stomach ulcers or bleeding problems
• take a blood thinning (anticoagulant) or steroid
drug
• take other drugs containing prescription NSAIDs
(aspirin, ibuprofen, naproxen, or others)
• have 3 or more alcoholic drinks every day while
using this product
• take more or for a longer time than directed
OTC - DO NOT USE SECTION
Do not use:
• if you have ever had an allergic reaction to any
other pain
• reliever/fever reducer
• right before or after heart surgery
• if you have ever had an allergic reaction to this
product or any of its ingredients
OTC - ASK DOCTOR SECTION
Ask a doctor before use if:
• stomach bleeding warning applies to you
• you have problems or serious side effects from
taking pain
• relievers or fever reducers
• you have a history of stomach problems, such
as heartburn
• you have high blood pressure, heart disease, liver
cirrhosis, kidney disease, or asthma
• you are taking a diuretic
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are:
• under a doctor’s care for any serious condition
• taking aspirin for heart attack or stroke, because
ibuprofen may decrease the benefit of aspirin
• taking the blood thinning drug Warfarin
OTC - WHEN USING SECTION
When using this product:
• take with food or milk if stomach upset occurs
• the risk of heart attack or stroke may increase if
you use more than directed or for longer than
directed
OTC - STOP USE SECTION
Stop use and ask a doctor if:
• you experience any of the following signs of
stomach bleeding:
• feel faint
• vomit blood
• have bloody or black stools
• have stomach pain that does not get better
• pain gets worse or lasts more than 10 days
• fever gets worse or lasts more than 3 days
• redness or swelling is present in the
painful area
• any new symptoms occur
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health
professional before use. It is especially important
not to use ibuprofen during the last 3 months of
pregnancy unless definitely directed to do so by a
doctor because it may cause problems in the
unborn child or complications during delivery.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose,
get medical help or contact a Poison Control Center
right away.
DOSAGE & ADMINISTRATION SECTION
Directions:
• do not take more than directed
• the smallest effective dose should be used
• adults and children 12 years and over: take 1 tablet
every 4 to 6 hours while symptoms persist
• if pain or fever does not respond to 1 tablet,
2 tablets may be used
• do not exceed 6 tablets in 24 hours, unless
directed by a doctor
• children under 12 years: ask a doctor
OTHER SAFETY INFORMATION
Other information:
read all warnings and directions before use. Keep
carton. Store at 20-25°C (68-77°F) avoid excessive
heat above 40°C (104°F)
INACTIVE INGREDIENT SECTION
Inactive Ingredients:
colloidal silicon dioxide, corn starch, sodium starch
glycollate, hypromellose, lactose monohydrate,
povidone, pregelatinized corn starch, red iron oxide,
sodium starch glycolate, steric acid, talc, titanium
dioxide, triacetin, purified water
Product Package
aramark
100 TABLETS PER BOX Part # 552R23
Ibuprofen
Anti-Inflammatory Fever
Reducer
Compare active ingredient to:
ADVIL®
Registered Trademark of Pfizer Consumer Healthcare
Retain carton for complete product information
MANUFACTURED FOR:
Aramark
Lenexa, KS 66219
(913) 269-9611
aramarkuniform.com
100 Tablet Box
250 Tablet Box
2-Tablet Packet
res
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81238-0103-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-129f-0266-e053-dadaa90a7c1a | Aramark Ibuprofen |
| 81238-0103-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-129f-0266-e053-dadaa90a7c1a | Aramark Ibuprofen |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81238-0103-1 | Aramark Ibuprofen | 50 in 1 BOX | TABLET | 50 | 2 | |
| 81238-0103-1 | Aramark Ibuprofen | 2 in 1 PACKET | TABLET | 2 | 2 | |
| 81238-0103-2 | Aramark Ibuprofen | 125 in 1 BOX | TABLET | 125 | 2 | |
| 81238-0103-2 | Aramark Ibuprofen | 2 in 1 PACKET | TABLET | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 81238-0103 | ARAMARK IBUPROFEN (IBUPROFEN) TABLET [WESTERN FIRST AID SAFETY DBA ARAMARK] | 2 | Legacy NDC, 4 package rows | 20210522_6481ca76-c9a6-4a15-84e4-4872e1b762ae.zip |
Products#
Every source-derived product name is available through these pages.
- Aramark Ibuprofen
- IBUPROFEN
- SILICON DIOXIDE
- STARCH, CORN
- SODIUM STARCH GLYCOLATE TYPE A
- HYPROMELLOSE, UNSPECIFIED
- LACTOSE MONOHYDRATE
- POVIDONE
- FERRIC OXIDE RED
- STEARIC ACID
- TALC
- TITANIUM DIOXIDE
- TRIACETIN
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 81238-0103 | 81238-0103-1, 81238-0103-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IBUPROFEN | WK2XYI10QM | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| SODIUM STARCH GLYCOLATE TYPE A | H8AV0SQX4D | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| POVIDONE | FZ989GH94E | IACT |
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b1a0cd90-c2ee-441f-a3d5-b0f100b68176 | 6481ca76-c9a6-4a15-84e4-4872e1b762ae | 2021-05-20 | Warnings | b1a0cd90-c2ee-441f-a3d5-b0f100b68176 6481ca76-c9a6-4a15-84e4-4872e1b762ae |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


